⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Hepassocin (HPS)
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-15 — Hepassocin prevents age-related liver senescence and facilitates liver regeneration by activating AMPK.: Mouse study (animal-model): hepassocin declines with age in mice and shows a correlative drop in humans; exogenous HPS rescued age-related liver senescence and restored regenerative capacity in aged mice, acting via an ANXA2–ERK–p90RSK–LKB1–AMPK cascade. [animal-model] (novelty: 3)
Open questions
Related
Contributing findings
Hepassocin prevents age-related liver senescence and facilitates liver regeneration by activating AMPK.
15-sep-2026
novelty 3
per-area 3
strengthens